| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 80053 |
Comprehensive metabolic panel |
5,684 |
4,521 |
$297K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
2,381 |
619 |
$183K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,375 |
4,753 |
$167K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
2,773 |
1,916 |
$138K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,666 |
1,432 |
$116K |
| 36415 |
Collection of venous blood by venipuncture |
7,461 |
5,431 |
$90K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,110 |
3,689 |
$85K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
986 |
899 |
$85K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,936 |
2,357 |
$80K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,847 |
1,555 |
$79K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
2,047 |
1,801 |
$74K |
| 84484 |
|
1,425 |
846 |
$67K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
4,038 |
3,424 |
$59K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
920 |
867 |
$57K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
703 |
646 |
$57K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,640 |
1,204 |
$56K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,893 |
1,718 |
$49K |
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
618 |
587 |
$46K |
| 80061 |
Lipid panel |
1,075 |
1,016 |
$45K |
| 71046 |
Radiologic examination, chest; 2 views |
787 |
703 |
$41K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,076 |
947 |
$41K |
| G0378 |
Hospital observation service, per hour |
273 |
93 |
$40K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
68 |
61 |
$39K |
| 70450 |
Computed tomography, head or brain; without contrast material |
141 |
117 |
$32K |
| 83735 |
|
1,245 |
1,015 |
$31K |
| 82550 |
|
1,046 |
753 |
$30K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
603 |
519 |
$30K |
| A0425 |
Ground mileage, per statute mile |
554 |
364 |
$29K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,000 |
920 |
$27K |
| 83721 |
|
880 |
833 |
$25K |
| 81003 |
|
2,006 |
1,631 |
$25K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
805 |
630 |
$25K |
| 71045 |
Radiologic examination, chest; single view |
546 |
427 |
$24K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
206 |
196 |
$24K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
564 |
513 |
$23K |
| 82553 |
|
462 |
292 |
$23K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,223 |
1,060 |
$20K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,449 |
1,229 |
$19K |
| 80305 |
|
588 |
494 |
$18K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
389 |
260 |
$17K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
603 |
429 |
$14K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
485 |
378 |
$13K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,487 |
1,369 |
$13K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
306 |
104 |
$12K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
379 |
259 |
$12K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
305 |
212 |
$11K |
| J7050 |
Infusion, normal saline solution, 250 cc |
629 |
445 |
$11K |
| 82607 |
|
362 |
342 |
$10K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
756 |
722 |
$10K |
| 97010 |
|
898 |
277 |
$10K |
| 83690 |
|
246 |
195 |
$9K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
355 |
262 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
191 |
183 |
$6K |
| 83605 |
|
267 |
211 |
$6K |
| 82150 |
|
96 |
74 |
$5K |
| 97014 |
|
154 |
58 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
495 |
441 |
$5K |
| 81025 |
|
122 |
99 |
$4K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
48 |
42 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
251 |
212 |
$3K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
285 |
145 |
$3K |
| 85610 |
|
115 |
93 |
$2K |
| 96376 |
|
69 |
39 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
164 |
126 |
$2K |
| A0427 |
Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) |
15 |
12 |
$2K |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
42 |
38 |
$2K |
| 82746 |
|
307 |
288 |
$1K |
| 84100 |
|
62 |
58 |
$1K |
| 72100 |
|
24 |
24 |
$1K |
| 0001A |
|
15 |
14 |
$798.00 |
| 80320 |
|
32 |
25 |
$677.55 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
12 |
12 |
$603.93 |
| 85730 |
|
33 |
28 |
$599.98 |
| 99441 |
|
74 |
65 |
$541.07 |
| 85378 |
|
13 |
12 |
$484.22 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
35 |
26 |
$328.14 |
| 87186 |
|
20 |
13 |
$285.65 |
| 87070 |
|
14 |
12 |
$230.07 |
| 99072 |
|
39 |
12 |
$194.04 |
| 99442 |
|
36 |
35 |
$90.51 |
| 91300 |
|
34 |
30 |
$0.00 |